UniXell Biotechnology

Shanghai, China · Founded 2021 · Privately Held (backing)

Developer of cellular therapy designed for human pluripotent stem cells. UniXell Biotechnology is based in Shanghai, China and was founded in 2021. It has raised $66.6 million.

Last price · $/share
—
Implied valuation
—
Total raised
$66.6M
Last round
—

Who backs UniXell Biotechnology?

21 investors
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

UniXell Biotechnology investors

21 investors are on record for UniXell Biotechnology, including GL Ventures, CDH Investments, Tencent Investment and Pudong Capital.

Free account
More of UniXell Biotechnology with a free account
  • ·The complete investor list: 21 names
  • ·Watch UniXell Biotechnology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 21 firms already write checks for companies like UniXell Biotechnology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View